不典型痣患者决策辅助中定量与定性风险框架的随机A/B测试
本研究采用随机A/B测试设计,600名美国成人观看定量或定性患者决策辅助(PDA),描述轻度、中度或重度不典型痣场景。定量PDA提高了自我报告的理解度(中位数80 vs 72;OR 1.04,95%CI 0.75-1.43;不典型痣严重程度显著增加切除意向(轻度31%、中度41%、重度72%;
要点
- 定量PDA改善理解度和决策信心,但不改变切除意向。
- 不典型痣严重程度标签是治疗意向的主要驱动因素。
- 约三分之一参与者尽管理解度高仍偏离专家建议。
核心结论
- 定量PDA增强理解,但不典型痣严重程度标签主导治疗意向。
研究设计与样本
- 随机A/B测试设计,600名美国成人观看定量或定性PDA,描述轻度、中度或重度不典型痣场景。
主要发现
- 约三分之一参与者偏离专家建议。
临床怎么用
- 临床可使用定量PDA提升患者理解和信心。
- 需注意严重程度标签可能过度影响治疗选择,应结合患者价值观讨论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient decision aids (PDAs) support shared decision-making by presenting treatment options clearly and objectively. However, little is known about how risk framing and diagnostic severity labels influence patient preferences in dermatology. OBJECTIVE: Assess how PDA format (quantitative vs qualitative) and dysplastic nevus severity (mild, moderate, or severe) affect understanding, risk perception, confidence, and treatment intent. METHODS: In this randomized A/B testing design, 600 US adults viewed a quantitative or qualitative PDA describing a mild, moderate, or severe dysplastic nevus scenario. Self-reported outcomes included understanding, treatment selection (excision vs monitoring), satisfaction, decision-making confidence, perceived melanoma risk, and concern. Analyses used nonparametric tests and logistic regression. RESULTS: Quantitative PDAs improved self-reported understanding (median 80 vs 72; P = .008) and confidence (P = .003) and lowered perceived melanoma risk for monitoring (P = .003) and excision (P < .001), but did not change excision intent (52% vs 53%; odds ratio 1.04, 95% CI 0.75-1.43; P = .818). Dysplastic nevus severity significantly increased excision intent (31% mild, 41% moderate, 72% severe; P < .001), without affecting understanding. CONCLUSION: Quantitative PDAs enhance comprehension, yet diagnostic severity labels predominantly drive treatment intent. Approximately one-third of participants diverged from expert recommendations despite high comprehension, underscoring that individual values drive treatment choices.
引用
- Roland-McGowan JN, Ose OM, Yu Y, et al. Quantitative versus qualitative risk framing in patient decision aids for dysplastic nevi: A randomized A/B testing study. J Am Acad Dermatol. 2026. PMID: 41893389. doi:10.1016/j.jaad.2026.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。